NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹347 Cr | ₹317 Cr | ₹261 Cr | ₹237 Cr | ₹60 Cr |
What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹347 Cr |
| Mar2025 | ₹317 Cr |
| Mar2024 | ₹261 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹60 Cr |
How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹347 Cr | 9.22 | |
| Mar2025 | ₹317 Cr | 21.53 | |
| Mar2024 | ₹261 Cr | 10.10 | |
| Mar2023 | ₹237 Cr | 292.81 | |
| Mar2022 | ₹60 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,101.6 Cr | 4% | 3.7% | 38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 4% |
3.7% |
38.8% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses